Cwm, LLC Bio N Tech Se Transaction History
Cwm, LLC
- $21.2 Billion
- Q2 2024
A detailed history of Cwm, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Cwm, LLC holds 1,302 shares of BNTX stock, worth $159,729. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,302
Previous 1,402
7.13%
Holding current value
$159,729
Previous $129,000
18.6%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BNTX
# of Institutions
328Shares Held
40.6MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$1.02 Billion0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$588 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$537 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$359 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$233 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...